Skip to main content

Animations

MJFF Publications

191 - 200 of 6422 Results
Title
Year
  • Year
  • 2013
  • 2013
  • 2015
  • 2017
  • 2017
  • 2010
  • 2006
  • 2008
  • 2009
  • 2015
  • Summary Details
    OPEN
    Title: Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse Model
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0061700
    Citation Count: 117
  • Summary Details
    OPEN
    Title: BACE1 Levels by APOE Genotype in Non-Demented and Alzheimer’s Post-Mortem Brains
    Journal Name: Current Alzheimer Research
    Publisher: Bentham Science Publishers Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2174/1567205011310030010
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Is PARKIN parkinsonism a cancer predisposition syndrome?
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000031
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Domain‐specific cognitive impairment in non‐demented Parkinson's disease psychosis
    Journal Name: International Journal of Geriatric Psychiatry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/gps.4736
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Parkinson disease–associatedLRRK2 G2019Stransgene disrupts marrow myelopoiesis and peripheral Th17 response
    Journal Name: Journal of Leukocyte Biology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1189/jlb.1a0417-147rr
    Citation Count: 30
  • Summary Details
    OPEN
    Title: CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s disease
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00702-010-0485-5
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.0602116103
    Citation Count: 137
  • Summary Details
    OPEN
    Title: Enantiomeric Propanolamines as selectiveN-Methyl-d-aspartate 2B Receptor Antagonists
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/jm8002153
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4)
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2009.07.072
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Reproducibility of a Parkinsonism‐related metabolic brain network in non‐human primates: A descriptive pilot study with FDG PET
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26302
    Citation Count: 18
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.